GlaxoSmithKline PLC Total Voting Rights (5386Y)
02 Gennaio 2020 - 10:58AM
UK Regulatory
TIDMGSK
RNS Number : 5386Y
GlaxoSmithKline PLC
02 January 2020
GlaxoSmithKline plc
Total Voting Rights and Capital
In conformity with the Financial Conduct Authority's Disclosure
Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the
'Company') hereby notifies the market of the following:
The Company's issued share capital as at 31 December 2019
consisted of 5,383,102,231 shares of 25 pence each ('Ordinary
Shares'), of which 393,505,950 Ordinary Shares were held in
Treasury.
Therefore, the total number of voting rights in the Company is
4,989,596,281. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.
V A Whyte
Company Secretary
2 January 2020
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TVRUPUQAGUPUUBP
(END) Dow Jones Newswires
January 02, 2020 04:58 ET (09:58 GMT)
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Apr 2023 a Apr 2024